Global Pre-Pregnancy Genetic Testing Market Size By Type (Chorionic Villi Sampling (CVS), Amniocentesis), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Pre-Pregnancy Genetic Testing Market was valued at USD 5.6 billion in 2023 and is projected to reach USD 11.3 billion by 2031, growing at a CAGR of 9.1% during the forecast period of 2023-2031.

The market's expansion is primarily driven by increasing awareness about genetic disorders, advancements in genetic screening technologies, and the rising preference for planned parenthood. Pre-pregnancy genetic testing is crucial in assessing potential hereditary conditions that may affect a child, helping couples make informed reproductive decisions. The growing prevalence of genetic diseases such as cystic fibrosis, sickle cell anemia, and thalassemia, coupled with increased accessibility to non-invasive and cost-effective screening techniques, is further fueling market growth.

Market Drivers

1. Rising Awareness and Demand for Preventive Healthcare

Growing awareness among couples regarding genetic risks and the benefits of early detection is driving the demand for pre-pregnancy genetic testing. Governments and healthcare organizations worldwide are launching awareness campaigns promoting genetic counseling and testing for potential hereditary conditions.

2. Advancements in Genetic Testing Technologies

The evolution of next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray techniques has significantly improved the accuracy, efficiency, and affordability of genetic testing. These advancements are making genetic screening more accessible and reliable.

3. Increasing Incidence of Genetic Disorders

The rising prevalence of inherited disorders and birth defects is a key factor propelling market growth. According to the World Health Organization (WHO), genetic conditions contribute to a significant percentage of infant mortality rates globally, leading to a greater emphasis on pre-pregnancy screening.

4. Growing Adoption of Personalized Medicine

The shift towards personalized healthcare solutions has increased the demand for genetic testing, as it enables couples to tailor pregnancy planning based on their genetic profiles. This trend is expected to drive significant market growth in the coming years.

Market Restraints

1. High Costs of Genetic Testing

Despite technological advancements, the cost of genetic tests remains high, particularly in low- and middle-income countries. Expensive procedures limit widespread adoption, especially among uninsured patients.

2. Ethical and Psychological Concerns

Pre-pregnancy genetic testing raises ethical dilemmas and emotional distress for couples, particularly when dealing with uncertain or unfavorable results. Concerns regarding genetic discrimination and privacy breaches also hinder adoption.

3. Limited Accessibility in Developing Regions

Developing economies lack the necessary infrastructure, trained professionals, and regulatory frameworks to support the widespread implementation of genetic screening programs. This factor continues to challenge market penetration.

Market Opportunities

1. Expansion of Direct-to-Consumer (DTC) Genetic Testing

The growing popularity of direct-to-consumer (DTC) genetic testing is creating new opportunities for the market. Companies offering at-home genetic test kits are making genetic screening more accessible to consumers without requiring a clinical visit.

2. Integration of Artificial Intelligence (AI) in Genetic Analysis

AI-driven genetic analysis tools enhance the accuracy of test results, reducing turnaround times and improving patient outcomes. The incorporation of AI and machine learning is expected to revolutionize genetic testing workflows.

3. Government Initiatives Supporting Genetic Research

Several governments are investing in genomic research and precision medicine initiatives, leading to higher adoption of genetic screening programs. This creates a lucrative market opportunity for key industry players.

Market by Test Type Insights

Carrier Screening Dominates Market Share

Based on test type, the Carrier Screening segment held the largest market share in 2023. Carrier screening tests detect recessive genetic conditions that could be passed down to offspring, allowing couples to make informed reproductive decisions.

The Aneuploidy Screening segment is projected to witness significant growth, driven by increasing awareness about chromosomal abnormalities such as Down syndrome, Turner syndrome, and Edwards syndrome.

Market by End-Use Insights

Hospitals & Diagnostic Laboratories Lead the Market

The Hospitals & Diagnostic Laboratories segment accounted for the largest revenue share in 2023, as hospitals serve as primary healthcare providers for genetic counseling and testing. Diagnostic labs are increasingly adopting automated genetic screening solutions to enhance test accuracy.

Meanwhile, Direct-to-Consumer (DTC) Testing is gaining traction, particularly in North America and Europe, due to its convenience, cost-effectiveness, and privacy features.

Market by Regional Insights

North America Dominates the Market

North America held the largest share in 2023, driven by high awareness, advanced healthcare infrastructure, and strong presence of genetic testing companies. The United States is the key contributor, with increasing adoption of genetic counseling programs.

Europe follows closely, with countries like Germany, the UK, and France witnessing a rise in government-funded screening programs.

Asia-Pacific is expected to witness the highest CAGR during the forecast period, fueled by growing healthcare investments, rising disposable income, and increased awareness about genetic disorders in countries such as China, India, and Japan.

Competitive Scenario

Key players in the Global Pre-Pregnancy Genetic Testing Market include:

Illumina, Inc.

Thermo Fisher Scientific, Inc.

Natera, Inc.

Quest Diagnostics Incorporated

Centogene N.V.

Laboratory Corporation of America Holdings (LabCorp)

Myriad Genetics, Inc.

Baylor Genetics

23andMe, Inc.

GeneDx, Inc.

These companies focus on product innovation, mergers & acquisitions, and strategic partnerships to strengthen their market position. For instance:

In 2023, Natera, Inc. launched an advanced next-generation carrier screening test, offering improved accuracy in detecting recessive genetic conditions.

In 2024, Quest Diagnostics expanded its genetic testing portfolio, integrating AI-driven diagnostic tools to enhance test accuracy.

In 2025, Myriad Genetics partnered with a leading fertility clinic to develop personalized pre-pregnancy genetic testing solutions.

Scope of Work – Global Pre-Pregnancy Genetic Testing Market

Report Metric Details

Market Size (2023) USD 5.6 billion

Projected Market Size (2031) USD 11.3 billion

CAGR (2023-2031) 9.1%

Key Segments Test Type (Carrier Screening, Aneuploidy Screening, PGD, Others), End-Use (Hospitals & Diagnostic Labs, Direct-to-Consumer)

Leading Region North America

Key Players Illumina, Thermo Fisher, Natera, Quest Diagnostics, Myriad Genetics, LabCorp, 23andMe

Market Drivers Rising genetic disorder awareness, technological advancements, demand for personalized medicine

Market Restraints High costs, ethical concerns, limited accessibility in developing regions

Market Opportunities DTC testing, AI integration in genetic analysis, government initiatives

FAQs

1. What is the current market size of the Global Pre-Pregnancy Genetic Testing Market?

The Global Pre-Pregnancy Genetic Testing Market was valued at USD 5.6 billion in 2023.

2. What is the major growth driver of the Global Pre-Pregnancy Genetic Testing Market?

The market is primarily driven by rising awareness about genetic disorders, advancements in genetic screening technologies, and increasing demand for personalized medicine.

3. Which is the largest region during the forecast period in the Global Pre-Pregnancy Genetic Testing Market?

North America holds the largest market share, while Asia-Pacific is expected to witness the fastest growth rate.

4. Which segment accounted for the largest market share in the Global Pre-Pregnancy Genetic Testing Market?

The Carrier Screening segment led the market in 2023 due to its importance in detecting hereditary genetic conditions.

5. Who are the key market players in the Global Pre-Pregnancy Genetic Testing Market?

Key players include Illumina, Thermo Fisher, Natera, Quest Diagnostics, Myriad Genetics, LabCorp, 23andMe, and GeneDx.